Please use this identifier to cite or link to this item:
https://ahro.austin.org.au/austinjspui/handle/1/13178
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Nayler, W G | en |
dc.date.accessioned | 2015-05-16T02:58:11Z | |
dc.date.available | 2015-05-16T02:58:11Z | |
dc.date.issued | 1994-05-16 | en |
dc.identifier.citation | Basic Research in Cardiology; 89 Suppl 1(): 137-43 | en |
dc.identifier.govdoc | 7945168 | en |
dc.identifier.other | PUBMED | en |
dc.identifier.uri | https://ahro.austin.org.au/austinjspui/handle/1/13178 | en |
dc.description.abstract | Atherosclerosis is a multifactorial disease which culminates in the ruptured plaque seen at autopsy. Hypercholesterolaemia, subintimal accumulation of lipid, monocyte adhesion followed by penetration across the endothelium, the conversion of monocytes to macrophages and smooth muscle cell proliferation and migration are some of the events involved in the early stages of lesion formation. Late events include the formation of excess ground substance and collagen, and the formation of the fibrotic cap. Young lesions tend to be more fragile than "old" calcified lesions, and it is these young lesions which rupture, haemorrhage and provide anchor points for platelets. Therapeutic interventions aimed at controlling lesion formation include those which reduce risk factors, including hypertension as well as those which interfere with the cascade of events involved in lesion formation. Agents which lower plasma cholesterol provide one approach. Another approach is to use calcium antagonists which not only lower blood pressure, but also directly interfere with some of the metabolic events involved in lesion formation. | en |
dc.language.iso | en | en |
dc.subject.other | Animals | en |
dc.subject.other | Aorta.metabolism.pathology | en |
dc.subject.other | Calcium.analysis | en |
dc.subject.other | Cholesterol.blood | en |
dc.subject.other | Cholesterol, Dietary | en |
dc.subject.other | Coronary Artery Disease.chemically induced.drug therapy | en |
dc.subject.other | Diet, Atherogenic | en |
dc.subject.other | Male | en |
dc.subject.other | Nifedipine.therapeutic use | en |
dc.subject.other | Nisoldipine.therapeutic use | en |
dc.subject.other | Rabbits | en |
dc.title | Therapeutic approaches to the control of coronary atherosclerosis. | en |
dc.type | Journal Article | en |
dc.identifier.journaltitle | Basic research in cardiology | en |
dc.identifier.affiliation | Department of Medicine, University of Melbourne, Austin Hospital, Heidelberg, Victoria, Australia | en |
dc.description.pages | 137-43 | en |
dc.relation.url | https://pubmed.ncbi.nlm.nih.gov/7945168 | en |
dc.type.austin | Journal Article | en |
item.openairetype | Journal Article | - |
item.cerifentitytype | Publications | - |
item.openairecristype | http://purl.org/coar/resource_type/c_18cf | - |
item.fulltext | No Fulltext | - |
item.grantfulltext | none | - |
item.languageiso639-1 | en | - |
Appears in Collections: | Journal articles |
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.